astaxanthin/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases systolic blood pressure (setting unspecified)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Subgroup analysis exhibited that the SBP was reduced significantly when AST was administered for more than 8 weeks (MD = −4.69; 95% CI = −9.23, −0.16; I2 = 0%; p = 0.04) (Supplementary File S6 Figure S4a).”
Quoted verbatim from Astaxanthin Influence on Health Outcomes of Adults at Risk of Metabolic Syndrome: A Systematic Review and Meta-Analysis.. - Study
- meta-analysis
- Population
- adults with metabolic syndrome risk factors; subgroup: AST administered for more than 8 weeks (pooled meta-analysis subgroup)
Effect -4.69 mean difference, 95% CI -9.23 to -0.16
Astaxanthin Influence on Health Outcomes of Adults at Risk of Metabolic Syndrome: A Systematic Review and Meta-Analysis.2022PMID:35631193Permalink
Keep reading
- Everything the graph holds on astaxanthin
- Every compound studied against Systolic blood pressure (setting unspecified)
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M1JY16BXS85QHSMNZPFS94EP